Roche’s phase III EMPACTA study showed Actemra/RoActemra reduced the likelihood of needing mechanical ventilation in hospitalised patients with COVID-19 associated pneumoniaGlobeNewsWire • 09/18/20
Roche to present a broad range of data across multiple cancer types at the ESMO Virtual Congress 2020GlobeNewsWire • 09/17/20
Roche receives FDA approval for expanded use of the CINtec PLUS Cytology test to aid clinicians in preventing cervical cancerGlobeNewsWire • 09/16/20
New data further reinforce Roche’s OCREVUS (ocrelizumab) as a highly effective treatment for people with multiple sclerosisGlobeNewsWire • 09/11/20
New data show Roche’s ENSPRYNG (satralizumab) significantly reduces severity and risk of relapse in neuromyelitis optica spectrum disorder (NMOSD)GlobeNewsWire • 09/10/20
Roche expands its multiple sclerosis portfolio with investigational BTK inhibitor fenebrutinib and initiates novel clinical trials for OCREVUS (ocrelizumab)GlobeNewsWire • 09/09/20
Roche receives FDA clearance for BK virus quantitative test on cobas 6800/8800 Systems to support better care for transplant patientsGlobeNewsWire • 09/08/20
Roche announces FDA approval of Gavreto (pralsetinib) for the treatment of adults with metastatic RET fusion-positive non-small cell lung cancerGlobeNewsWire • 09/07/20
Roche receives FDA Emergency Use Authorization for the cobas SARS-CoV-2 & Influenza A/B Test for use on the cobas 6800/8800 SystemsGlobeNewsWire • 09/04/20
Roche to present new data in multiple sclerosis and neuromyelitis optica spectrum disorder at MSVirtual2020GlobeNewsWire • 09/03/20
Roche To Launch Rapid COVID-19 Test In Europe This Month, Seek FDA Emergency Use ApprovalBenzinga • 09/02/20
Roche to launch new rapid coronavirus test in Europe later this month following regulatory clearanceCNBC • 09/01/20
Roche to launch SARS-CoV-2 Rapid Antigen Test in countries accepting CE mark, allowing fast triage decisions at point of careGlobeNewsWire • 09/01/20
Roche receives FDA approval for first HIV-1/HIV-2 Qualitative Test on the cobas 6800/8800 Systems in the fight against HIV/AIDSGlobeNewsWire • 09/01/20
Roche announces FDA approval of FoundationOne Liquid CDx, a comprehensive pan-tumour liquid biopsy testGlobeNewsWire • 08/28/20
COVID-19 Treatments: Remdesivir Disappoints, Antiviral SPL7013 And Monoclonal Antibodies Interesting For Prevention/Early-Stage TreatmentSeeking Alpha • 08/27/20
PTC reports first milestone payment from Roche for spinal muscular atrophy drugMarket Watch • 08/26/20
A Virtual Drug Discovery Company—with No Lab Of Its Own—partners With Roche To Fight Cancers In The BrainForbes • 08/25/20
Blueprint Maintains Independence, Roche Gets Competitor for Eli Lilly Drug in $775 Million DealGuruFocus • 08/24/20